← Insiders

GEVO

Neutral signalScored 2026-08-27 Drivers: fundamentals. Moteurs : fondamentaux.

Research, not advice.

À propos

Gevo, Inc.

Nom
Gevo, Inc.
Secteur
Basic Materials
Industrie
Chemicals - Specialty
Bourse
NASDAQ
Capitalisation
$284.3M
Employés
151
PDG
Paul D. Bloom
Site web
https://gevo.com
Marché
ADURASIXGPREKOPKROLWLG

Gevo, Inc. is a company focused on the development and commercialization of renewable fuels. Its operations are organized into four distinct segments: Gevo, Agri-Energy, Renewable Natural Gas, and Net-Zero. The company's primary objective is to offer sustainable alternatives for gasoline, jet fuel, and diesel, striving to achieve zero carbon emissions and substantially lower overall greenhouse gas footprints. Their diverse product offerings include renewable versions of gasoline and diesel, sustainable aviation fuel (SAF), and renewable natural gas. Additionally, they produce specialty chemicals like isooctane, isobutanol, isobutylene, and ethanol, along with animal feed and protein. Gevo, Inc. has formed a strategic partnership with Axens North America, Inc. to advance ethanol-to-jet technology and further the commercial development of sustainable aviation fuel projects. Originally founded in 2005 as Methanotech, Inc., the company changed its name to Gevo, Inc. in March 2006. Its corporate headquarters are located in Englewood, Colorado.

Price (1 year)

Live chart from TradingView — independent market data, as price context around the filings, not the Quorum score. EMA 50/200 and Bollinger load by default. When the exchange is known it is sent as EXCHANGE:SYMBOL; otherwise TradingView resolves the ticker best-effort.

ACHAT TOTAL: 50 000 titres (~77 000,00 $ US) VENTE TOTALE: 283 585 titres (~430 144,02 $ US)

Insiders
Bloom Paul DGruber Patrick R.Barber James J
Total bought
$77,000

Avg buy (VWAP, 90d window) $1.54 vs last close —

Total sold
$476,121

Avg sell (VWAP, 90d window) $1.52 vs last close —

Total sold sums Form 4 code S in this window. Codes F, M, A and G are left out.

$476,121 of that total is under a Rule 10b5-1 plan. It is shown here and left out of the score.

Last activity
2026-09-03
Last synced
2026-09-09 09:58:02 Synced via automated research pipeline

Sign in to request a sync of this company's price history and timing levels.

Insider holdings as a share of total assets aren't available for this company.

Avg buy and avg sell are volume-weighted prices (sum of shares × price, divided by shares) for Form 4 rows in this 90-day window that report both figures. A comparison with last close is market context for that average, not advice.

Recent Form 4

Filings in the 90-day window for this company. Value is shares × price from the filing. Research, not advice.

Date Person Side Shares Price Value Form 4
2026-09-03 Bloom Paul D Sell · S · 10b5-1 1,514 $1.71 $2,589 Form 4
2026-09-03 Bowron Kimberly T Sell · S · 10b5-1 1,221 $1.71 $2,088 Form 4
2026-09-03 Gruber Patrick R. Sell · S · 10b5-1 3,333 $1.70 $5,671 Form 4
2026-08-21 Barber James J Buy · P 50,000 $1.54 $77,000 Form 4
2026-08-21 Kettner David Michael Buy · P 12,500 $1.55 $19,369 Form 4
2026-08-06 Agiri Oluwagbemileke Yusuf Sell · S · 10b5-1 18,223 $1.54 $28,034 Form 4
2026-08-06 Bloom Paul D Sell · S · 10b5-1 31,096 $1.55 $48,068 Form 4
2026-08-06 Bowron Kimberly T Sell · S · 10b5-1 10,257 $1.55 $15,855 Form 4
2026-08-06 Gruber Patrick R. Sell · S · 10b5-1 247,642 $1.51 $373,816 Form 4

Sales marked 10b5-1 are scheduled in advance and don't count toward the Quorum score. Les ventes marquées 10b5-1 sont planifiées à l'avance et ne pèsent pas dans le score Quorum.

Congressional trades

STOCK Act disclosures (90-day window)

Amounts are STOCK Act brackets as disclosed. Quorum does not turn a bracket into an exact price or a midpoint.

No STOCK Act disclosures for this company in this window.

Recent trades

DateRepresentativeTypeAmount
2025-07-02Ro KhannaSale$1,001 - $15,000
2024-11-01Ro KhannaSale$1,001 - $15,000
2024-11-01Ro KhannaPurchase$1,001 - $15,000
2022-12-12Chris JacobsPurchase$1,001 - $15,000
2022-11-08Chris JacobsSale (Full)$1,001 - $15,000
2022-07-18Chris JacobsSale (Partial)$1,001 - $15,000

Signal

Neutral signalScored 2026-08-27 Drivers: fundamentals. Moteurs : fondamentaux.

GEVO presents a meaningful earnings catalyst with a revenue beat and raised EBITDA guidance, supported by strong low-carbon fuels momentum and high catalyst confidence (0.8), but the weak financial health scores…

The first sentence of the analysis written for GEVO on 2026-08-27 - a real excerpt, not a sample. The rest of it, the 0-100 score and the rating it produced are part of Plus. See plans.

Neutral signal Drivers: fundamentals. Moteurs : fondamentaux.

Factor checklist — research, not advice

A check leans with a bullish reading. A cross leans against it. A dash is unavailable or mixed.

  • Insider Supports a bullish reading. Open-market purchases outweigh sales
  • Congress Unavailable or mixed. No purchase disclosures in the stored window
  • Narrative Unavailable or mixed. Stored narrative reading is in the neutral band
  • Timing Unavailable or mixed. No stored price series
  • Financial indicators Unavailable or mixed. Current ratio 1.82 · operating margin -12% — readings disagree

Market snapshot

Financial ratios

MetricTrend2025-12-312024-12-312023-12-312022-12-312021-12-31
Gross Profit Margin30.2%29.0%30.3%-640.3%-1342.2%
Ebit Margin-9.4%-442.0%-372.4%-8241.7%-11060.4%
Ebitda Margin6.4%-333.8%-261.9%-7570.5%-10098.3%
Operating Profit Margin-11.7%-536.9%-475.8%-8739.2%-11307.3%
Pretax Profit Margin-20.3%-464.9%-385.0%-8341.0%-11107.5%
Continuous Operations Profit Margin-20.3%-464.9%-385.0%-8341.0%-11107.5%
Net Profit Margin-21.1%-464.9%-385.0%-8341.0%-11107.5%
Bottom Line Profit Margin-21.1%-464.9%-385.0%-8341.0%-11107.5%
Current Ratio1.8258.3624.22616.33211.981
Quick Ratio1.8778.1774.18516.08311.886
Solvency Ratio-0.034-0.639-0.508-0.946-0.551
Cash Ratio0.0147.7743.2639.3221.404
Price To Earnings Ratio-14.286-6.147-4.143-4.318-14.267
Price To Earnings Growth Ratio0.243-0.2870.114-0.0930.247
Forward Price To Earnings Growth Ratio0.243-0.2870.114-0.0930.247
Price To Earnings Diluted Ratio-14.286-6.147-4.143-4.318-14.267
Price To Earnings Diluted Growth Ratio0.243-0.2870.114-0.0930.247
Price To Book Ratio1.0040.9890.4970.6951.531
Price To Sales Ratio2.91528.62516.098358.2301,572.234
Price To Free Cash Flow Ratio-10.756-4.464-2.560-3.278-7.337
Price To Operating Cash Flow Ratio-34.924-8.438-5.154-9.499-17.360
Debt To Assets Ratio0.2330.1210.1080.0990.108
Debt To Equity Ratio0.3590.1440.1260.1150.128
Debt To Capital Ratio0.2640.1260.1120.1030.113
Long Term Debt To Capital Ratio0.2610.1210.0000.1000.109
Financial Leverage Ratio1.5421.1931.1671.1571.179
Working Capital Turnover Ratio1.3150.0710.0500.0030.003
Operating Cash Flow Ratio-0.171-2.356-0.588-1.742-1.659
Operating Cash Flow Sales Ratio-0.083-3.392-3.123-37.711-90.565
Free Cash Flow Operating Cash Flow Ratio3.2471.8902.0142.8982.366
Debt Service Coverage Ratio0.584-14.478-0.641-67.084-131.599
Interest Coverage Ratio-1.074-23.414-37.869-87.991-240.112
Short Term Operating Cash Flow Coverage Ratio0.000-2,732.524-0.789-278.686-305.513
Operating Cash Flow Coverage Ratio-0.080-0.813-0.765-0.636-0.691
Capital Expenditure Coverage Ratio-0.445-1.123-0.986-0.527-0.732
Dividend Paid And Capex Coverage Ratio-0.445-1.123-0.986-0.527-0.732
Dividend Payout Ratio0.0000.0000.0000.0000.000
Enterprise Value Multiple61.874-6.472-1.081-2.850-16.109

Sparkline shows each ratio oldest → newest (left → right).

How the latest year compares

For each ratio: its most recent value, the change versus one year earlier, and versus its 5-year average. ▲ higher ▼ lower

MetricCurrentvs 1Y agovs 5Y avg
Gross Profit Margin 30.2% ▲1.2% ▲408.8%
Ebit Margin -9.4% ▲432.6% ▲4015.8%
Ebitda Margin 6.4% ▲340.2% ▲3658.0%
Operating Profit Margin -11.8% ▲525.2% ▲4202.5%
Pretax Profit Margin -20.3% ▲444.6% ▲4043.4%
Continuous Operations Profit Margin -20.3% ▲444.6% ▲4043.4%
Net Profit Margin -21.1% ▲443.8% ▲4042.8%
Bottom Line Profit Margin -21.1% ▲443.8% ▲4042.8%
Current Ratio 1.825 ▼-6.537 ▼-6.720
Quick Ratio 1.877 ▼-6.301 ▼-6.565
Solvency Ratio -0.034 ▲0.605 ▲0.501
Cash Ratio 0.014 ▼-7.760 ▼-4.342
Price To Earnings Ratio -14.286 ▼-8.139 ▼-5.654
Price To Earnings Growth Ratio 0.243 ▲0.530 ▲0.198
Forward Price To Earnings Growth Ratio 0.243 ▲0.530 ▲0.198
Price To Earnings Diluted Ratio -14.286 ▼-8.139 ▼-5.654
Price To Earnings Diluted Growth Ratio 0.243 ▲0.530 ▲0.198
Price To Book Ratio 1.004 ▲0.014 ▲0.060
Price To Sales Ratio 2.914 ▼-25.711 ▼-392.706
Price To Free Cash Flow Ratio -10.756 ▼-6.292 ▼-5.077
Price To Operating Cash Flow Ratio -34.924 ▼-26.486 ▼-19.849
Debt To Assets Ratio 0.233 ▲0.112 ▲0.099
Debt To Equity Ratio 0.359 ▲0.215 ▲0.185
Debt To Capital Ratio 0.264 ▲0.138 ▲0.121
Long Term Debt To Capital Ratio 0.261 ▲0.141 ▲0.143
Financial Leverage Ratio 1.542 ▲0.349 ▲0.294
Working Capital Turnover Ratio 1.315 ▲1.244 ▲1.027
Operating Cash Flow Ratio -0.171 ▲2.185 ▲1.133
Operating Cash Flow Sales Ratio -0.084 ▲3.309 ▲26.892
Free Cash Flow Operating Cash Flow Ratio 3.247 ▲1.357 ▲0.764
Debt Service Coverage Ratio 0.584 ▲15.062 ▲43.227
Interest Coverage Ratio -1.074 ▲22.340 ▲77.018
Short Term Operating Cash Flow Coverage Ratio 0.000 ▲2732.524 ▲663.502
Operating Cash Flow Coverage Ratio -0.080 ▲0.733 ▲0.517
Capital Expenditure Coverage Ratio -0.445 ▲0.678 ▲0.318
Dividend Paid And Capex Coverage Ratio -0.445 ▲0.678 ▲0.318
Dividend Payout Ratio 0.000 0.000 0.000
Enterprise Value Multiple 61.874 ▲68.346 ▲54.801

Key metrics

MetricTrend20252024202320222021
Market cap$468.0M$484.2M$276.9M$420.9M$838.0M
Enterprise value$634.5M$365.4M$48.7M$253.5M$867.1M
EV / Sales3.95x21.60x2.83x215.73x1626.75x
EV / Op. cash flow-47.34x-6.37x-0.91x-5.72x-17.96x
EV / Free cash flow-14.58x-3.37x-0.45x-1.97x-7.59x
EV / EBITDA61.87x-6.47x-1.08x-2.85x-16.11x
Net debt / EBITDA16.23x2.10x5.07x1.88x-0.54x
Current ratio1.82x8.36x4.23x16.33x11.98x
Income quality0.41x0.73x0.81x0.45x0.81x
Graham net-net-$1$0$1$1$1
Tax burden103.7%100.0%100.0%100.0%100.0%
Interest burden216.5%105.2%103.4%101.2%100.4%
Working capital$64.8M$179.3M$295.0M$390.0M$319.4M
Invested capital$173.3M$415.8M$514.6M$576.1M$468.8M
Return on assets-4.7%-13.5%-10.2%-14.0%-9.2%
Operating ROA-2.9%-14.7%-12.1%-15.3%-15.1%
Return on tangible assets-5.8%-13.7%-10.3%-14.1%-9.3%
Return on equity-7.3%-16.1%-11.9%-16.2%-10.8%
Return on invested capital-2.9%-16.2%-13.0%-15.2%-9.8%
Return on capital employed-2.9%-16.2%-14.6%-15.2%-9.8%
Earnings yield-7.2%-16.2%-23.9%-23.3%-7.1%
Free cash flow yield-9.3%-22.4%-39.1%-30.5%-13.6%
Capex / Op. cash flow-224.7%-89.0%-101.4%-189.8%-136.6%
Capex / Depreciation110.1%279.2%286.5%1066.1%1285.9%
Capex / Sales18.8%302.0%316.6%7156.3%12371.5%
SG&A / Sales31.9%270.8%247.8%3399.2%4782.9%
R&D / Sales2.8%140.4%38.6%1488.3%3256.3%
Stock comp / Sales5.7%87.1%99.3%1482.5%1852.5%
Intangibles / Total assets19.3%2.0%1.0%1.1%1.4%
Days sales outstanding21d68d84d148d1717d
Days payables outstanding4d16d83d210d229d
Operating cycle8d205d200d414d1848d
Cash conversion cycle5d188d117d204d1619d

Change by theme

Grouped by what each metric measures. Each figure is the change over the period shown — ▲ up ▼ down versus then.

Change over 1 year

Valuation
Market cap ▼-3.3%EV / Sales ▼-81.7%EV / EBITDA ▲+1056.0%EV / Op. cash flow ▼-40.975Earnings yield ▲+0.090
Profitability
Return on equity ▲+0.088Return on assets ▲+0.088Return on invested capital ▲+0.132Return on capital employed ▲+0.133Operating ROA ▲+0.118Income quality ▼-0.319Tax burden ▲+0.037
Efficiency
Days sales outstanding ▼-46.457Days payables outstanding ▼-12.864Operating cycle ▼-196.600Cash conversion cycle ▼-183.736Capex / Sales ▼-2.833R&D / Sales ▼-1.375
Balance-sheet strength
Current ratio ▼-6.537Net debt / EBITDA ▲+14.128Working capital ▼-114531000.000Invested capital ▼-242535000.000Intangibles / Total assets ▲+0.172

Change over 5 years

Valuation
Market cap ▼-44.2%EV / Sales ▼-99.8%EV / EBITDA ▲+484.1%EV / Op. cash flow ▼-29.381Earnings yield ▼-0.002
Profitability
Return on equity ▲+0.036Return on assets ▲+0.045Return on invested capital ▲+0.068Return on capital employed ▲+0.068Operating ROA ▲+0.122Income quality ▼-0.405Tax burden ▲+0.037
Efficiency
Days sales outstanding ▼-1696.165Days payables outstanding ▼-225.814Operating cycle ▼-1840.020Cash conversion cycle ▼-1614.206Capex / Sales ▼-123.527R&D / Sales ▼-32.535
Balance-sheet strength
Current ratio ▼-10.156Net debt / EBITDA ▲+16.771Working capital ▼-254631000.000Invested capital ▼-295513000.000Intangibles / Total assets ▲+0.179

Employee count

Peer market caps

Recent news